Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2028

Conditions
Metastatic Malignant Skin NeoplasmMetastatic Malignant Soft Tissue NeoplasmRecurrent Malignant Skin NeoplasmRecurrent Malignant Soft Tissue NeoplasmSkin NeoplasmSoft Tissue Neoplasm
Interventions
PROCEDURE

Biopsy Procedure

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Computed Tomography

Undergo CT

OTHER

Medical Device Usage and Evaluation

Undergo MBRT with tungsten slit collimator

RADIATION

Minibeam Radiation Therapy

Undergo MBRT with tungsten slit collimator

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT07062003 - Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial | Biotech Hunter | Biotech Hunter